Notice of results and investor presentation

RNS Number : 6225I
Plant Health Care PLC
19 April 2022
 

RNS

19 April 2022

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

Notice of Results and Investor Presentation

Plant Health Care®(AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that it intends to release its 2021 Annual Report on 12th May 2022. Further, Dr. Christopher Richards, CEO, Jeffrey Hovey, CFO, and Jeffrey Tweedy, COO, will provide a live presentation to update investors via the Investor Meet Company platform on 12th May 2022 at 3:00 p.m. (GMT).

The Company is committed to ensuring that there are appropriate communication structures for all elements of its shareholder base so that its strategy, business model and performance are clearly understood.

The online presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your IMC dashboard up until 9am the day before the meeting or any time during the live presentation

Investors can sign up to Investor Meet Company for free and add to meet Plant Health Care plc via:  https://www.investormeetcompany.com/plant-health-care-plc/register-investor

Investors who already follow Plant Health Care plc on the Investor Meet Company platform will automatically be invited.

For further information, please contact:

Plant Health Care plc


Chris Richards, CEO

+1 919 926 1600

Arden Partners plc - Nomad & Joint Broker


John Llewellyn-Lloyd / Antonio Bossi

+44 (0) 20 7614 5900

Cenkos Securities plc - Joint Broker


Neil McDonald / Peter Lynch

+44 (0) 20 7391 8900

Vox Markets - Digital Investor Relations


Paul Cornelius / Kat Perez

+44 (0) 7866 384707

 

Company website:  www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORUKSURUSUSAAR
UK 100

Latest directors dealings